These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 8299638)
1. Heparin after angioplasty: an unresolved issue? More RS; Brack MJ; Gershlick AH Eur Heart J; 1993 Nov; 14(11):1543-7. PubMed ID: 8299638 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of recombinant hirudin (CGP 39,393/TMREVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled study. Herrman JP; Simon R; Umans VA; Peerboom PF; Keane D; Rijnierse JJ; Bach D; Kobi P; Kerry R; Close P Eur Heart J; 1995 Nov; 16 Suppl L():56-62. PubMed ID: 8869020 [TBL] [Abstract][Full Text] [Related]
3. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty. Preisack MB; Karsch KR Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331 [TBL] [Abstract][Full Text] [Related]
4. The paradigm of restenosis following percutaneous transluminal coronary angioplasty. Preisack MB; Karsch KR Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774 [TBL] [Abstract][Full Text] [Related]
5. Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty. Oberhoff M; Novak S; Herdeg C; Baumbach A; Kranzhöfer A; Bohnet A; Horch B; Hanke H; Haase KK; Karsch KR Cardiovasc Res; 1998 Jun; 38(3):751-62. PubMed ID: 9747444 [TBL] [Abstract][Full Text] [Related]
6. [Restenosis after coronary angioplasty: status in 1994]. Vojácek J Vnitr Lek; 1995 May; 41(5):325-31. PubMed ID: 7653063 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing coronary intervention. Ragosta M; Karve M; Brezynski D; Humphries J; Sanders JM; Sarembock IJ; Gimple LW; Powers ER Am Heart J; 1999 Feb; 137(2):250-7. PubMed ID: 9924158 [TBL] [Abstract][Full Text] [Related]
8. Is heparin still necessary after primary angioplasty in the era of platelet glycoprotein IIb/IIIa receptor inhibitors? A review of the literature. Lettieri C; De Servi S; Buffoli F; Aroldi M; Baccaglioni N; Romano M; Tomasi L; Izzo A; Zanini R J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):653-9. PubMed ID: 16932077 [TBL] [Abstract][Full Text] [Related]
9. [Prospective randomized study of argatroban versus heparin anticoagulation therapy after percutaneous coronary intervention for acute myocardial infarction]. Hirahara T; Kubo N; Ohmura N; Matsushima K; Fujii M; Yasu T; Ikeda N; Saito M J Cardiol; 2004 Aug; 44(2):47-52. PubMed ID: 15373236 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies on the mechanisms of action of four polysaccharides on arterial restenosis. Deux JF; Meddahi-Pellé A; Bree F; Bataille I; Michel JB; Letourneur D J Biomater Sci Polym Ed; 2009; 20(5-6):689-702. PubMed ID: 19323884 [TBL] [Abstract][Full Text] [Related]
14. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results. Popma JJ; Satler LF J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090 [TBL] [Abstract][Full Text] [Related]
15. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883 [TBL] [Abstract][Full Text] [Related]
16. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis. Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911 [TBL] [Abstract][Full Text] [Related]
17. Safety of low dose heparin in elective coronary angioplasty. Koch KT; Piek JJ; de Winter RJ; David GK; Mulder K; Tijssen JG; Lie KI Heart; 1997 Jun; 77(6):517-22. PubMed ID: 9227294 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty. Grassman ED; Leya F; Fareed J; Lewis BE; Bacher P; Loeb HS; Moran JF J Invasive Cardiol; 2001 Nov; 13(11):723-8. PubMed ID: 11689712 [TBL] [Abstract][Full Text] [Related]
19. Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty. Rath B; Bennett DH Br Heart J; 1990 Jan; 63(1):18-21. PubMed ID: 2178656 [TBL] [Abstract][Full Text] [Related]
20. Angiographic observations 10 years following coronary laser balloon angioplasty. Glazier JJ; Spears JR J Interv Cardiol; 2005 Oct; 18(5):357-60. PubMed ID: 16202111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]